These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27018380)

  • 1. Effects of change in FreeSurfer version on classification accuracy of patients with Alzheimer's disease and mild cognitive impairment.
    Chepkoech JL; Walhovd KB; Grydeland H; Fjell AM;
    Hum Brain Mapp; 2016 May; 37(5):1831-41. PubMed ID: 27018380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer's Disease?
    Clerx L; Gronenschild EH; Echavarri C; Verhey F; Aalten P; Jacobs HI
    Curr Alzheimer Res; 2015; 12(4):358-67. PubMed ID: 25817249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data.
    Cho Y; Seong JK; Jeong Y; Shin SY;
    Neuroimage; 2012 Feb; 59(3):2217-30. PubMed ID: 22008371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter.
    Gong NJ; Chan CC; Leung LM; Wong CS; Dibb R; Liu C
    Hum Brain Mapp; 2017 May; 38(5):2495-2508. PubMed ID: 28176436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced detection of cortical atrophy in Alzheimer's disease using structural MRI with anatomically constrained longitudinal registration.
    Iannopollo E; Garcia K;
    Hum Brain Mapp; 2021 Aug; 42(11):3576-3592. PubMed ID: 33988265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and sensitivity of two whole-brain segmentation approaches included in FreeSurfer - ASEG and SAMSEG.
    Sederevičius D; Vidal-Piñeiro D; Sørensen Ø; van Leemput K; Iglesias JE; Dalca AV; Greve DN; Fischl B; Bjørnerud A; Walhovd KB; Fjell AM;
    Neuroimage; 2021 Aug; 237():118113. PubMed ID: 33940143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.
    Westman E; Aguilar C; Muehlboeck JS; Simmons A
    Brain Topogr; 2013 Jan; 26(1):9-23. PubMed ID: 22890700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical signature of clock drawing performance in Alzheimer's disease and mild cognitive impairment.
    Hirjak D; Wolf RC; Pfeifer B; Kubera KM; Thomann AK; Seidl U; Maier-Hein KH; Schröder J; Thomann PA
    J Psychiatr Res; 2017 Jul; 90():133-142. PubMed ID: 28284155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    Wittens MMJ; Sima DM; Houbrechts R; Ribbens A; Niemantsverdriet E; Fransen E; Bastin C; Benoit F; Bergmans B; Bier JC; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; de la Rosa E; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2021; 83(2):623-639. PubMed ID: 34334402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstructural brain changes track cognitive decline in mild cognitive impairment.
    Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
    Neuroimage Clin; 2018; 20():883-891. PubMed ID: 30290303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
    Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
    Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Choi M; Youn H; Kim D; Lee S; Suh S; Seong JK; Jeong HG; Han CE
    PLoS One; 2019; 14(8):e0220739. PubMed ID: 31369629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
    Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ensemble learning system for a 4-way classification of Alzheimer's disease and mild cognitive impairment.
    Yao D; Calhoun VD; Fu Z; Du Y; Sui J
    J Neurosci Methods; 2018 May; 302():75-81. PubMed ID: 29578038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.